A RESPONSE TO “THE POTENTIAL LONG-TERM COMPARATIVE EFFECTIVENESS OF LAROTRECTINIB AND ENTRECTINIB FOR SECOND-LINE TREATMENT OF TRK FUSION-POSITIVE METASTATIC LUNG CANCER”

Detalles Bibliográficos
Autores principales: Ogale, Sarika, Zerbini, Clarissa Emy Higuchi, Antoniou, Miranta, Freund, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391022/
https://www.ncbi.nlm.nih.gov/pubmed/33251994
http://dx.doi.org/10.18553/jmcp.2020.26.12.1616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391022/
https://www.ncbi.nlm.nih.gov/pubmed/33251994
http://dx.doi.org/10.18553/jmcp.2020.26.12.1616

Ejemplares similares